ABT•benzinga•
Raymond James Maintains Outperform on Abbott Laboratories, Raises Price Target to $142
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on April 17, 2025 by benzinga